Expert Comparison: Wegovy vs Mounjaro Mechanisms & Pricing
What Is Better Mounjaro or Wegovy: Understanding the Key Differences
When patients ask what is better Mounjaro or Wegovy, the answer depends on individual medical history and treatment goals rather than one being universally superior. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics natural fullness hormones, whilst Mounjaro uses tirzepatide, which targets both GIP and GLP-1 receptors simultaneously. This dual-action mechanism means Mounjaro works through two complementary pathways, potentially offering different benefits for appetite regulation and glucose control. Both medications are prescription-only medicines that require clinical assessment and ongoing medical supervision.
The Wegovy vs Mounjaro decision often comes down to practical considerations alongside clinical factors. Wegovy follows a five-dose escalation schedule (0.25mg to 2.4mg) over 16 weeks, whilst Mounjaro uses six doses (2.5mg to 15mg) with a different titration pattern. Your prescriber will consider factors including your BMI, existing medical conditions, previous treatment responses, and lifestyle requirements. At EverydayMeds, our clinical team can assess both options during your consultation, ensuring you receive the most appropriate prescription-only medicine for your weight management journey.
Wegovy vs Mounjaro Pricing: Complete Cost Comparison
Understanding what is better Mounjaro or Wegovy from a cost perspective requires comparing the complete treatment journey rather than individual pen prices. Wegovy pricing at EverydayMeds starts with the 0.25mg dose at £79.99, progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to the maintenance 2.4mg dose at £209.99. Our Getting Started bundles provide convenient dose progression, with the Intro Duo (0.25mg & 0.5mg) priced at £169.99 and Progress Duo (0.5mg & 1mg) at £189.99. New customers apply code FIRST40 at checkout, whilst returning customers use DOSE25, with both codes already factored into our displayed pricing.
Mounjaro pricing follows a different structure due to its unique dosing schedule, and direct cost comparisons can be misleading without considering individual treatment duration and effectiveness. The Wegovy vs Mounjaro cost equation includes factors beyond the medication price, such as consultation frequency, monitoring requirements, and treatment duration to achieve goals. Our 3-pen bundles offer extended supply security, with options like the Gentle Start Trio (£269.99) providing flexible dosing for patients who need slower escalation. Both treatments include our comprehensive service with 3-minute online assessment, prescriber review, and temperature-controlled next-day delivery.
Clinical Evidence: What Is Better Mounjaro or Wegovy Based on Research?
The clinical evidence for what is better Mounjaro or Wegovy comes from separate trial programmes that cannot be directly compared due to different study designs and patient populations. Wegovy's evidence base includes the landmark STEP trials, with STEP 1 demonstrating average weight loss of approximately 15% at 68 weeks when combined with lifestyle interventions, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial showed a 20% reduction in major cardiovascular events, highlighting benefits beyond weight management.
Mounjaro's clinical programme used different endpoints and patient populations, making direct percentage comparisons inappropriate and potentially misleading. Both medications demonstrated significant efficacy in their respective trials when used alongside reduced-calorie diet and increased physical activity. The choice between treatments should be based on individual patient factors rather than comparing trial outcomes, as real-world effectiveness depends on adherence, tolerance, and personal response to each medication's distinct mechanism of action.
How Wegovy Works: GLP-1 Mechanism for Weight Management
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the action of naturally occurring incretin hormones produced in the intestine after eating. This mechanism helps regulate appetite by acting on brain centres responsible for hunger and satiety signals, potentially reducing food cravings and promoting feelings of fullness after smaller meals. The medication also slows gastric emptying, which contributes to prolonged satiety and may help patients feel satisfied with reduced portion sizes. Additionally, GLP-1 receptor activation can influence glucose-dependent insulin secretion, providing metabolic benefits beyond appetite regulation. The once-weekly injection schedule helps maintain consistent medication levels, supporting steady appetite control throughout the week. As a prescription-only medicine, Wegovy requires careful medical supervision to monitor effectiveness and manage any potential side effects during treatment.
EverydayMeds Ordering Process: From Assessment to Delivery
Our streamlined ordering process makes accessing both Wegovy and Mounjaro straightforward whilst maintaining clinical safety standards required for prescription-only medicines. The journey begins with our 3-minute online clinical assessment, which captures essential medical history, current medications, previous weight management attempts, and treatment goals. Your responses are reviewed by our qualified prescribers (GPhC #9012878), with standard review taking up to 3 working days or express 24-hour service available for urgent requirements. Once approved, your prescription is dispensed from our registered UK pharmacy and dispatched via temperature-controlled cold-chain delivery to ensure medication integrity. All orders include comprehensive patient information leaflets, injection guidance, and access to our clinical support team for ongoing questions during treatment.
Storage and Practical Considerations: Wegovy vs Mounjaro Comparison
Storage requirements present a key practical difference when considering what is better Mounjaro or Wegovy for your lifestyle needs. Wegovy can be stored at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, whilst Mounjaro allows only 21 days at room temperature, making Wegovy more convenient for travel or patients without reliable refrigeration access. Both medications require initial storage at 2-8°C and use pre-filled FlexTouch pen devices for easy self-administration. The dose escalation schedules differ significantly, with Wegovy following a structured 4-week progression through each dose level, whilst Mounjaro uses its own titration pattern designed to minimise gastrointestinal side effects. Injection technique is similar for both medications, with once-weekly subcutaneous administration typically in the thigh, abdomen, or upper arm. Patients must follow the prescribed escalation schedule and cannot skip doses, as gradual increases help improve tolerability whilst achieving therapeutic effectiveness.
Individual Factors: Determining What Is Better Mounjaro or Wegovy for You
The question of what is better Mounjaro or Wegovy ultimately depends on individual medical factors that only a qualified prescriber can properly evaluate during clinical assessment. Patients with type 2 diabetes may find their prescriber considers different factors compared to those seeking weight management alone, as both medications can affect glucose control through distinct mechanisms. Previous experience with GLP-1 medications, family history of thyroid conditions, gastroparesis risk, and current medication interactions all influence treatment selection.
Lifestyle considerations also play a crucial role in the Wegovy vs Mounjaro decision-making process. Business travellers might prefer Wegovy's extended room temperature storage, whilst patients sensitive to injection volume or needle gauge might have preferences between the different pen devices. Some patients respond better to single-target medications like Wegovy's GLP-1 mechanism, whilst others may benefit from Mounjaro's dual-receptor approach. Our clinical team at EverydayMeds can explore these individual factors during your assessment, ensuring the chosen treatment aligns with both your medical profile and practical requirements.
Making Your Choice: Both Wegovy and Mounjaro Available at EverydayMeds
Rather than choosing what is better Mounjaro or Wegovy before clinical assessment, we recommend discussing both options with our qualified prescribers who can evaluate your individual circumstances comprehensively. Both medications are available through our regulated pharmacy (GPhC #9012878) with identical service standards including clinical assessment, prescriber review, and next-day cold-chain delivery. New customers can use code FIRST40 at checkout, whilst returning customers apply code DOSE25, with transparent pricing clearly displayed for all dose options and bundle configurations. Our clinical team provides ongoing support throughout your treatment journey, whether you start with Wegovy, Mounjaro, or potentially switch between treatments based on response and tolerance. Visit our weight management collection at https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment and discover which option our prescribers recommend for your specific goals and medical profile.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
